U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C23H24O8
Molecular Weight 428.4319
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of WORTMANNIN

SMILES

COC[C@H]1OC(=O)C2=COC3=C2[C@@]1(C)C4=C([C@@H]5CCC(=O)[C@@]5(C)C[C@H]4OC(C)=O)C3=O

InChI

InChIKey=QDLHCMPXEPAAMD-QAIWCSMKSA-N
InChI=1S/C23H24O8/c1-10(24)30-13-7-22(2)12(5-6-14(22)25)16-18(13)23(3)15(9-28-4)31-21(27)11-8-29-20(17(11)23)19(16)26/h8,12-13,15H,5-7,9H2,1-4H3/t12-,13+,15+,22-,23-/m0/s1

HIDE SMILES / InChI

Molecular Formula C23H24O8
Molecular Weight 428.4319
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/7667888

Wortmannin is a fungal metabolite that so far has been shown to act as a selective inhibitor of phosphoinositide 3-kinase. Wortmannin inhibits cancer cell growth and has shown activity against mouse and human tumor xenografts in mice. Wortmannin is the first described PI3K inhibitor with IC50 of 3 nM in a cell-free assay, with little selectivity within the PI3K family. Also blocks autophagosome formation and potently inhibits DNA-PK/ATM with IC50 of 16 nM and 150 nM in cell-free assays.

Approval Year

PubMed

PubMed

TitleDatePubMed
Phosphatidylinositol 3-kinase, not extracellular signal-regulated kinase, regulates activation of the antioxidant-responsive element in IMR-32 human neuroblastoma cells.
2001-06-08
P2Y(2) nucleotide receptor signaling in human monocytic cells: activation, desensitization and coupling to mitogen-activated protein kinases.
2001-05
Trypanosoma cruzi: phosphatidylinositol 3-kinase and protein kinase B activation is associated with parasite invasion.
2001-04-01
Proinsulin C-peptide rapidly stimulates mitogen-activated protein kinases in Swiss 3T3 fibroblasts: requirement of protein kinase C, phosphoinositide 3-kinase and pertussis toxin-sensitive G-protein.
2001-04-01
Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of beta-catenin.
2001-04-01
Beta(2)-adrenergic receptors potentiate glucocorticoid receptor transactivation via G protein beta gamma-subunits and the phosphoinositide 3-kinase pathway.
2001-04
Regulatory role of phosphatidylinositol 3-kinase on TNF-alpha-induced cyclooxygenase 2 expression in colonic epithelial cells.
2001-04
Intracellular Angiotensin II and cell growth of vascular smooth muscle cells.
2001-04
p110-related PI 3-kinases regulate phagosome-phagosome fusion and phagosomal pH through a PKB/Akt dependent pathway in Dictyostelium.
2001-04
Insulin increases the turnover rate of Na+-K+-ATPase in human fibroblasts.
2001-04
Mechanism by which wortmannin and LY294002 inhibit catecholamine secretion in the rat adrenal medullary cells.
2001-04
Pleiotrophin induces angiogenesis: involvement of the phosphoinositide-3 kinase but not the nitric oxide synthase pathways.
2001-04
The cell survival signal Akt is differentially activated by PDGF-BB, EGF, and FGF-2 in osteoblastic cells.
2001-03-26
Oxidative stress induced by ascorbate causes neuronal damage in an in vitro system.
2001-03-23
A novel family of phosphatidylinositol 4-kinases conserved from yeast to humans.
2001-03-16
Reduction of potassium currents and phosphatidylinositol 3-kinase-dependent AKT phosphorylation by tumor necrosis factor-(alpha) rescues axotomized retinal ganglion cells from retrograde cell death in vivo.
2001-03-15
A low-pH culture condition enhances the radiosensitizing effect of wortmannin.
2001-03-15
PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model.
2001-03-15
Study of the cytolethal distending toxin (CDT)-activated cell cycle checkpoint. Involvement of the CHK2 kinase.
2001-03-02
Activation of BMK1 via tyrosine 1062 in RET by GDNF and MEN2A mutation.
2001-03-02
TNFalpha elicits association of PI 3-kinase with the p60TNFR and activation of PI 3-kinase in adherent neutrophils.
2001-03-02
Activation of phosphatidylinositol-3 kinase (PI-3K) and extracellular regulated kinases (Erk1/2) is involved in muscarinic receptor-mediated DNA synthesis in neural progenitor cells.
2001-03-01
Induction of the monocytic differentiation of myeloid leukaemia cells by cotylenin A, a plant growth regulator.
2001-03
Biosynthesis and processing of cathepsin K in cultured human osteoclasts.
2001-03
Human rad21 gene, hHR21(SP), is downregulated by hypoxia in human tumor cells.
2001-03
Integrin signaling via the PI3-kinase-Akt pathway increases neuronal resistance to glutamate-induced apoptosis.
2001-03
Rac recruits high-affinity integrin alphavbeta3 to lamellipodia in endothelial cell migration.
2001-03
Insulin regulation of protein translation repressor 4E-BP1, an eIF4E-binding protein, in renal epithelial cells.
2001-03
Resistance to induced apoptosis in the human neuroblastoma cell line SK-N-SH in relation to neuronal differentiation. Role of Bcl-2 protein family.
2001-03
Phosphoinositide 3-kinase, but not mitogen-activated protein kinase, pathway is involved in hepatocyte growth factor-mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes.
2001-03
Roles of phosphatidylinositol 3-kinase and phospholipase D in temporal activation of superoxide production in FMLP-stimulated human neutrophils.
2001-03
Regulation of p42/p44 MAPK and p38 MAPK by the adenosine A(1) receptor in DDT(1)MF-2 cells.
2001-02-16
Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.
2001-02-15
Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle.
2001-02
Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells.
2001-02
Signaling events mediating the additive effects of oleic acid and angiotensin II on vascular smooth muscle cell migration.
2001-02
Molecular mechanisms for the antiapoptotic action of gastrin.
2001-02
Insulin signal transduction in rat small intestine: role of MAP kinases in expression of mucosal hydrolases.
2001-02
Involvement of PI 3-kinase in IGF-I stimulation of jejunal Na+-K+-ATPase activity and nutrient absorption.
2001-02
Insulin-like growth factor-I is a potential trophic factor for amacrine cells.
2001-02
Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2.
2001-01-01
Beta1 integrin activation on human neutrophils promotes beta2 integrin-mediated adhesion to fibronectin.
2001-01
Hypoxia activates Akt and induces phosphorylation of GSK-3 in PC12 cells.
2001-01
Regulation of intracellular trafficking of the EGF receptor by Rab5 in the absence of phosphatidylinositol 3-kinase activity.
2001-01
Evidence that phosphorylation of human Upfl protein varies with intracellular location and is mediated by a wortmannin-sensitive and rapamycin-sensitive PI 3-kinase-related kinase signaling pathway.
2001-01
Phosphatidylinositol 3-kinase activity is required for the expression of glial fibrillary acidic protein upon cAMP-dependent induction of differentiation in rat C6 glioma.
2001-01
Survival activity of troglitazone in rat motoneurones.
2001-01
Early growth response factor-1 mediates insulin-inducible vascular endothelial cell proliferation and regrowth after injury.
2001
Involvement of p70 S6 kinase in bone morphogenetic protein signaling: vascular endothelial growth factor synthesis by bone morphogenetic protein-4 in osteoblasts.
2001
17 beta-estradiol-BSA conjugates and 17 beta-estradiol regulate growth plate chondrocytes by common membrane associated mechanisms involving PKC dependent and independent signal transduction.
2001
Patents

Sample Use Guides

6 mg/kg, administered intraperitoneally
Route of Administration: Intraperitoneal
In Vitro Use Guide
In MCF-7 cells less than 30% of the total PtdIns-3-kinase activity is inhibited by 10 nM wortmannin.
Substance Class Chemical
Created
by admin
on Mon Mar 31 22:28:12 GMT 2025
Edited
by admin
on Mon Mar 31 22:28:12 GMT 2025
Record UNII
XVA4O219QW
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
WORTMANNIN
MI  
Common Name English
NSC-627609
Preferred Name English
KY-12420
Common Name English
(+)-WORTMANNIN
Common Name English
3H-FURO(4,3,2-DE)INDENO(4,5-H)-2-BENZOPYRAN-3,6,9-TRIONE, 11-(ACETYLOXY)-1,6B,7,8,9A,10,11,11B-OCTAHYDRO-1-(METHOXYMETHYL)-9A,11B-DIMETHYL-, (1S,6BR,9AS,11R,11BR)-
Systematic Name English
WORTMANNIN [MI]
Common Name English
SL-2052
Code English
Classification Tree Code System Code
NCI_THESAURUS C2152
Created by admin on Mon Mar 31 22:28:12 GMT 2025 , Edited by admin on Mon Mar 31 22:28:12 GMT 2025
Code System Code Type Description
MERCK INDEX
m11521
Created by admin on Mon Mar 31 22:28:12 GMT 2025 , Edited by admin on Mon Mar 31 22:28:12 GMT 2025
PRIMARY Merck Index
PUBCHEM
312145
Created by admin on Mon Mar 31 22:28:12 GMT 2025 , Edited by admin on Mon Mar 31 22:28:12 GMT 2025
PRIMARY
EPA CompTox
DTXSID8040642
Created by admin on Mon Mar 31 22:28:12 GMT 2025 , Edited by admin on Mon Mar 31 22:28:12 GMT 2025
PRIMARY
CAS
19545-26-7
Created by admin on Mon Mar 31 22:28:12 GMT 2025 , Edited by admin on Mon Mar 31 22:28:12 GMT 2025
PRIMARY
NSC
627609
Created by admin on Mon Mar 31 22:28:12 GMT 2025 , Edited by admin on Mon Mar 31 22:28:12 GMT 2025
PRIMARY
DRUG BANK
DB08059
Created by admin on Mon Mar 31 22:28:12 GMT 2025 , Edited by admin on Mon Mar 31 22:28:12 GMT 2025
PRIMARY
WIKIPEDIA
Wortmannin
Created by admin on Mon Mar 31 22:28:12 GMT 2025 , Edited by admin on Mon Mar 31 22:28:12 GMT 2025
PRIMARY
NCI_THESAURUS
C1277
Created by admin on Mon Mar 31 22:28:12 GMT 2025 , Edited by admin on Mon Mar 31 22:28:12 GMT 2025
PRIMARY NCIT
FDA UNII
XVA4O219QW
Created by admin on Mon Mar 31 22:28:12 GMT 2025 , Edited by admin on Mon Mar 31 22:28:12 GMT 2025
PRIMARY